Display Settings:

Format

Send to:

Choose Destination
    J Clin Pharmacol. 1992 Jun;32(6):536-8.

    Cholestyramine-induced hyperchloremic metabolic acidosis.

    Source

    Division of Nephrology, Johns Hopkins University, School of Medicine, Baltimore, Maryland 21205.

    Abstract

    Cholestyramine is a nonabsorbable anion exchange resin that is used predominantly for the treatment of hypercholesterolemia in adults and the management of acute diarrhea in children. The authors report two cases of severe hyperchloremic nonanion gap metabolic acidosis associated with the use of cholestyramine therapy. The authors recommend that patients taking cholestyramine who have concomitant renal insufficiency or who are volume depleted or who are taking spironolactone be monitored carefully for the emergence of a hyperchloremic metabolic acidosis.

    PMID:
    1634640
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk